Clinical investigators play a vital role in bringing new and potentially life-saving medicines to markets faster, which in turn enables millions of people all over the world to live longer, healthier and happier lives.

ICON has worked on studies for over 350 of the world’s leading pharmaceutical, biotechnology and medical device companies. The studies have spanned all phases of the drug development cycle and have been in every major therapeutic area.

Over the years we have successfully built a close network of some of the world’s leading investigators who are supported by ICON’s senior scientists and clinicians. As well as contributing to the development of new drugs, investigators have been able to increase the availability of new drugs to their patients. 

We are always keen to increase our investigator pool and to work with the finest, most qualified investigators to advance the field of medicine.

If you would like to be considered for future clinical trials run by ICON, click on the links in the Related Information toolbar to register your information. Your information will be used by ICON staff to identify potential sites for upcoming trials.

Please note that by registering you automatically give ICON your permission to store the entered data electronically and process it as necessary for selection and contact purposes regarding new clinical trials.

Preclinical/Phase I trials


Phase II - IIIb trials